PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

被引：0
|
作者：
Karin Beelen
Mark Opdam
Tesa M Severson
Rutger HT Koornstra
Andrew D Vincent
Jelle Wesseling
Jettie J Muris
Els MJJ Berns
Jan B Vermorken
Paul J van Diest
Sabine C Linn
机构：
[1] The Netherlands Cancer Institute,Departments of Molecular Biology
[2] The Netherlands Cancer Institute,Departments of Biometrics
[3] The Netherlands Cancer Institute,Departments of Pathology
[4] Erasmus University Medical Center- Cancer Center,Department of Medical Oncology
[5] Antwerp University Hospital,Department of Medical Oncology
[6] University Medical Center Utrecht,Department of Pathology
[7] The Netherlands Cancer Institute,Departments of Medical Oncology
来源：
Breast Cancer Research | / 16卷
关键词：
Tamoxifen; Molecular Alteration; PIK3CA Mutation; Adjuvant Tamoxifen; Endocrine Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Tissue
    Schmidt, Carolin
    Stoehr, Robert
    Dimitrova, Lora
    Beckmann, Matthias W.
    Ruebner, Matthias
    Fasching, Peter A.
    Denkert, Carsten
    Lehmann, Ulrich
    Vollbrecht, Claudia
    Haller, Florian
    Hartmann, Arndt
    Erber, Ramona
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (07): : 624 - 637
  • [22] Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
    Gasch, Christin
    Bauernhofer, Thomas
    Pichler, Martin
    Langer-Freitag, Sabine
    Reeh, Matthias
    Seifert, Adrian M.
    Mauermann, Oliver
    Izbicki, Jakob R.
    Pantel, Klaus
    Riethdorf, Sabine
    CLINICAL CHEMISTRY, 2013, 59 (01) : 252 - 260
  • [23] Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor
    Chen, JM
    Stavro, PM
    Thompson, LU
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2002, 43 (02): : 187 - 192
  • [24] Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal Cancer
    Takahari, Daisuke
    Yamada, Yasuhide
    Okita, Natuko T.
    Honda, Takuya
    Hirashima, Yoshinori
    Matsubara, Junichi
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    Shirao, Kuniaki
    Shimada, Yasuhiro
    Shimoda, Tadakazu
    ONCOLOGY, 2009, 76 (01) : 42 - 48
  • [25] Relationship of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer
    Takahari, D.
    Yamada, Y.
    Okita, N.
    Hirashima, Y.
    Matsubara, J.
    Takashima, A.
    Kato, K.
    Hamaguchi, T.
    Shirao, K.
    Shimada, Y.
    Shimoda, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma
    Xia, Michelle
    Overman, Michael J.
    Rashid, Asif
    Chatterjee, Deyali
    Wang, Hua
    Katz, Matthew H.
    Fleming, Jason B.
    Lee, Jeffery E.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Wang, Huamin
    HUMAN PATHOLOGY, 2015, 46 (09) : 1315 - 1322
  • [27] Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
    Desbois-Mouthon, Christele
    Baron, Aurore
    Blivet-Van Eggelpoel, Marie-Jose
    Fartoux, Laetitia
    Venot, Corinne
    Bladt, Friedhelm
    Housset, Chantal
    Rosmorduc, Olivier
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5445 - 5456
  • [28] Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer
    Matsubara, Junichi
    Yamada, Yasuhide
    Hirashima, Yoshinori
    Takahari, Daisuke
    Okita, Natsuko T.
    Kato, Ken
    Hamaguchi, Tetsuya
    Shirao, Kuniaki
    Shimada, Yasuhiro
    Shimoda, Tadakazu
    CLINICAL CANCER RESEARCH, 2008, 14 (10) : 3022 - 3029
  • [29] Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer
    Henry, Kelly E.
    Ulaner, Gary A.
    Lewis, Jason S.
    PET CLINICS, 2018, 13 (03) : 423 - +
  • [30] Immunohistochemical evaluation of insulin-like growth factor receptor 1 in breast cancer
    Batinic-Skipina, Danijela
    Maric, Radmil
    Tadic-Latinovic, Ljiljana
    Eric, Drazan
    Lalovic, Nenad
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2018, 146 (9-10) : 524 - 529
12345